bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Select Page

Sputum analysis by flow cytometry; an effective platform to analyze the lung environment

by Maria Zannes | Aug 17, 2022 | Publications

“Sputum analysis by flow cytometry; an effective platform to analyze the lung environment” PLoS ONE – August 17, 2022   Authors Bederka L.H., Sanchez JR, Rebeles J, Araujo PR, Grayson MH, Lai S-C, et al.   Abstract Low-dose computed tomography...

Quality-Controlled Sputum Analysis by Flow Cytometry

by Maria Zannes | Aug 9, 2021 | Publications

Journal of Visualized Experiments (JoVE) – August 9, 2021 AuthorsMarcia Grayson, Shao-Chiang Lai, Lydia H. Bederka, Patricia Araujo, Jamila Sanchez, Xavier T. Reveles, Vivienne I. Rebel, Jennifer Rebeles AbstractSputum, widely used to study the cellular content and...

Meso-tetra (4-carboMeso-tetra (4-carboxyphenyl) Porphyrin (TCPP) is taken up in Cancer Cells by the CD320 Receptor

by Maria Zannes | Jul 2, 2021 | Publications

“Meso-tetra (4-carboMeso-tetra (4-carboxyphenyl) porphyrin (TCPP) is taken up in cancer cells by the CD320 receptor” International Conference on Porphyrins and Phthalocyanines (ICPP) ICPP-11, June 26 through July 2, 2021   Authors David J. Elzi, William E. Bauta,...

Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors

by Maria Zannes | Jun 25, 2021 | Publications

“Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors” RNA Therapeutics Institute’s 2021 RNA Therapeutics Symposium at the University of Massachusetts Medical School June 23 – 25, 2021   Authors David J. Elzi, William E. Bauta,...

Simultaneous knockdown of CD320 and LRP2 receptors is selectively toxic to cancer cells but not normal cells

by Maria Zannes | May 22, 2021 | Publications

“Simultaneous knockdown of CD320 and LRP2 receptors is selectively toxic to cancer cells but not normal cells” At the American Association of Cancer Research (AACR) Annual Meeting 2021, April-May, 2021   Authors David J. Elzi, William Bauta,...

Identification of a novel mechanism for meso‐tetra (4‐carboxyphenyl) porphyrin (TCPP) uptake in cancer cells

by Maria Zannes | Feb 25, 2021 | Publications

“Identification of a novel mechanism for meso‐tetra (4‐carboxyphenyl) porphyrin (TCPP) uptake in cancer cells” Journal of the Federation of Societies for the Study of Experimental Biology (FASEB Journal), Feb. 25, 2021   Authors David J. Elzi, William E....
« Older Entries
Next Entries »

Categories

  • Articles (29)
  • Events (38)
  • News (54)
  • Press Releases (165)
  • Publications (19)

Recent Posts

  • bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment April 28, 2026
  • New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy April 14, 2026
  • bioAffinity Technologies’ CyPath® Lung to be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16 April 7, 2026
  • bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026 April 1, 2026
  • bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice March 25, 2026
CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Copyright © 2023 bioAffinity Technologies, Inc.